MENA emerging as trial destination says ClinTec CEO

from Outsourcing-Pharma Podcast · host William Reed Ltd

Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.

Episode metadata supplied by the publisher feed · Published Feb 8, 2010

Embed this episode

Attribution link and audio player

NOW PLAYING

MENA emerging as trial destination says ClinTec CEO

0:00 5:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Outsourcing-Pharma Podcast?

This episode is 5 minutes long.

When was this Outsourcing-Pharma Podcast episode published?

This episode was published on February 8, 2010.

Can I download this Outsourcing-Pharma Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!